Tuesday, February 22, 2005

Weak law blamed in Vioxx case

From The Globe and Mail:
Canadian regulators say they lack the power to force drug companies to research specific safety concerns once a medication is on the market, despite the suspicion of heart-attack risk that swirled around Vioxx and other painkillers for years.

Mark Bethiaume, director of Health Canada's marketed pharmaceuticals division, said those who feel the department failed to protect the public from the dangers of Vioxx and other cox-2 drugs misunderstand Health Canada's abilities. ...more

No comments: